| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |